11
P&G’s $3.8B Power Move: Buying Thorne, CEO Confirms
Procter & Gamble Buys Supplement Brand Thorne for $3.8 Billion: What You Need to Know
The Big News in Simple Terms
Imagine a giant company that makes things like toothpaste, laundry detergent, and diapers deciding to buy a popular vitamin company. That’s exactly what happened! Procter & Gamble (P&G) — the massive company behind brands like Tide, Crest, and Pampers — just announced it’s buying Thorne, a well-known supplement brand, for $3.8 billion.
Important Point: This deal shows how big companies are racing to get into the booming health and wellness market, especially to reach younger shoppers.
Why Did P&G Buy Thorne?
P&G isn’t just buying a vitamin company for fun. Here are the main reasons:
1. Growing Their Health & Wellness Division
P&G already owns several health brands:
- Metamucil (fiber supplements)
- Align Probiotic (gut health)
- New Chapter (vitamins)
- Oral-B (toothbrushes)
- Vicks (cold/flu remedies)
Thorne fits perfectly into this "healthcare family."
2. Reaching Younger Customers
- Most Thorne buyers are under 40 years old
- P&G wants to connect with this younger demographic
- Thorne has seen a huge jump in direct-to-consumer sales (people buying straight from their website)
3. The Supplement Trend Is Exploding
More people than ever are taking vitamins and supplements for:
- Better sleep
- More energy
- Overall health improvement
- The "Make America Healthy Again" movement (led by Robert F. Kennedy Jr.) has also boosted interest
Thorne’s Journey: From Startup to $3.8 Billion Deal
| Year | Milestone |
|---|---|
| 1984 | Thorne founded |
| 2021 | Went public (valuation: $525 million) |
| 2023 | Taken private by L Catterton (deal value: $680 million) |
| 2025 | Annual revenue surpasses $500 million |
| 2026 | P&G agrees to buy for $3.8 billion |
Important Point: Thorne’s CEO Colin Watts predicted the brand could become a billion-dollar business within a few years. P&G is betting he’s right!
What This Means for the Industry
Other Big Companies Are Doing the Same Thing
- Unilever (makes Dove, Ben & Jerry’s) recently bought Grüns — a gummy supplement brand
- This is a pattern: giant consumer companies buying trendy, premium health brands
P&G’s Bigger Strategy
- P&G’s latest quarter showed flat volume (not selling more stuff)
- Revenue was worse than expected
- Their healthcare segment performed the worst by volume
- Buying Thorne is part of fixing this by owning "relevant, premium brands"
How the Market Reacted
- P&G shares went up less than 1% on Tuesday morning
- Investors are cautiously optimistic but waiting to see how the integration goes
Summary
In a nutshell: Procter & Gamble is spending $3.8 billion to buy Thorne, a fast-growing supplement brand popular with people under 40. This move helps P&G:
- Expand its health and wellness portfolio
- Reach younger consumers
- Capitalize on the booming supplement trend
- Fix slowing growth in its healthcare division
It’s part of a bigger wave where household-name companies are buying trendy health brands to stay relevant.
Frequently Asked Questions
1. Who owns Procter & Gamble?
P&G is a publicly traded company (NYSE: PG) owned by shareholders. It’s one of the world’s largest consumer goods companies, founded in 1837.
2. What makes Thorne different from other vitamin brands?
Thorne focuses on high-quality, science-backed supplements and sells directly to consumers online. They’re known for rigorous testing and premium positioning.
3. Will Thorne products change after P&G buys them?
Usually, big companies keep successful brands running independently at first. Thorne’s CEO and team will likely stay in place, but they’ll have P&G’s massive distribution and resources behind them.
4. Why are supplements so popular right now?
People are more focused on preventive health, personalized wellness, and natural solutions. Social media, influencer marketing, and movements like "Make America Healthy Again" have accelerated the trend.
5. Is $3.8 billion a lot for a supplement company?
For context: Thorne did $500M+ in revenue in 2025. The $3.8B price tag is about 7.6x revenue — a premium price reflecting Thorne’s growth potential, brand strength, and young customer base.
